No photo of Michael G Ison

View Scopus Profile

Michael G Ison

  • 4569 Citations
19972022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My primary clinical and research area focuses on infections in transplant recipients. My research is further focused on viral infections including norovirus, CMV and respiratory viral infections (influenza, adenovirus) in transplant recipients.

Care of the transplant recipient with infections.

Certifications and Licenses

Infectious Disease

Training Experience

2000Residency, Oregon Health Sciences University Hospital
2004Fellowship, University of Virginia Hospitals

Education/Academic qualification

MS, University of Virginia

… → 2004

MD, U Of South Florida

… → 1997

Research interests

  • Immunization
  • Infectious Diseases
  • Infectious Diseases: Viral
  • Respiratory Diseases
  • Transplantation
  • Virology
  • Virus Diseases

Fingerprint Dive into the research topics where Michael G Ison is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Human Influenza Medicine & Life Sciences
Transplants Medicine & Life Sciences
Organ Transplantation Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Tissue Donors Medicine & Life Sciences
Infection Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Respiratory Tract Infections Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2022

Protocol No. P10934-CMVPS-CSP-01: Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

Ison, M. G.

Hologic, Inc.

5/2/19 → 5/2/22

Project: Research project

Prot. CP40617 - A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Assess the Efficacy and Safety of Baloxavir Marboxil in Combination with a Neuraminidase Inhibitor versus a Neuraminidase Inhibitor Alone in Hospitalized Patien

Ison, M. G.

Syneos Health, Inc., Genentech, Inc.

2/22/19 → 2/22/22

Project: Research project

Prot. Number IA-001: A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating the Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients with Serious Influenza A Infection

Ison, M. G.

SGS North America Inc., Cangene Corporation

12/15/17 → 12/15/20

Project: Research project

AIC316-03-II-01 A Randomized, Open Label, Multi-Center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-Resistant Mucocutaneous HSV Infections in Immunocompromised Adults (PRIOH-1)

Ison, M. G.

Medpace, Inc., AiCuris Anti-infective Cures GmbH

12/1/17 → 12/1/20

Project: Research project

Protocol 9766-CL-0111 - A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species Protocol for Phase 4 Study of ASP9766

Ison, M. G.

inVentiv Health Clinical, Astellas Pharma Global Development, Inc.

4/7/17 → 4/7/20

Project: Research project

Research Output 1997 2019

Case 20-2019: A 52-year-old woman with fever and rash after heart transplantation

Ison, M. G., Lebeis, T. A., Barros, N., Lewis, G. D. & Massoth, L. R., Jun 27 2019, In : New England Journal of Medicine. 380, 26, p. 2564-2573 10 p.

Research output: Contribution to journal › Article

Heart Transplantation
Exanthema
Fever
Cardiology
Exercise Test
1 Citation (Scopus)

Clinical development of therapeutic agents for hospitalized patients with influenza: Challenges and innovations

King, J. C., Beigel, J. H., Ison, M. G., Rothman, R. E., Uyeki, T. M., Walker, R. E., Neaton, J. D., Tegeris, J. S., Zhou, J. A., Armstrong, K. L., Carter, W., Miele, P. S., Willis, M. S., Dugas, A. F., Tracy, L. R. A., Vock, D. M. & Bright, R. A., Apr 1 2019, In : Open Forum Infectious Diseases. 6, 4

Research output: Contribution to journal › Article

Open Access
Proxy
Human Influenza
Triage
Therapeutics
Hospital Emergency Service
14 Citations (Scopus)

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza

Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., Ison, M. G., Johnston, B. L., Knight, S. L., McGeer, A., Riley, L. E., Wolfe, C. R., Alexander, P. E. & Pavia, A. T., Mar 5 2019, In : Clinical Infectious Diseases. 68, 6, p. 895-902 8 p.

Research output: Contribution to journal › Review article

Open Access
Chemoprevention
Practice Guidelines
Human Influenza
Disease Outbreaks
Therapeutics

Community-acquired respiratory viruses in solid organ transplant

Nam, H. H. & Ison, M. G., Aug 1 2019, In : Current opinion in organ transplantation. 24, 4, p. 483-489 7 p.

Research output: Contribution to journal › Review article

Viruses
Transplants
Orthomyxoviridae
Molecular Pathology
Immunoglobulin Isotypes
3 Citations (Scopus)

Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

the AST Infectious Diseases Community of Practice, Jan 1 2019, In : Clinical Transplantation. e13547.

Research output: Contribution to journal › Article

Communicable Diseases
Guidelines
Infection
HIV
Infectious Disease Transmission